Advamedica
PrivateLast Round
Series B
Extension
Jul 27, 2021
Total Funding Raised
$21M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Advamedica operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B Extension round in July 2021.
Advamedica is a medical technology company that develops biomaterials-based medical devices for managing trauma, surgical, and chronic wounds.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Advamedica Comparables
Compare Advamedica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beeken Biomedical | 86% | |
| CELOX Medical | 85% | |
| Core Scientific Creations | 83% |
For institutional investors. Book with your work email.
Advamedica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 27, 2021 | ||||
| Series B Extension | Jan 9, 2020 | ||||
| Series B | Jan 26, 2018 | ||||
| Series A | May 25, 2016 | ||||
| Grant | Sep 11, 2013 | ||||
Seed | Dec 3, 2010 |
For institutional investors. Book with your work email.
Advamedica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GVFL | Seed |
| Omidyar Network India | Series B Extension |
| Department of Science & Technology | Grant |
| TrueScale Capital | Series B Extension |
| Chiratae Ventures | Series A, Series B Extension, Series B |
| RNT Associates | Series B |
| Accel | Series A, Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 52% MoM.
- Jan 26, 2018
$7.4M round led by RNT Associates.
For institutional investors. Book with your work email.
Advamedica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Advamedica's valuation, stock price, and market status.
Is Advamedica a public or private company?
Advamedica is a private company.
What is the current stock price of Advamedica?
Advamedica is a private company, so its shares have no public market price. Caplight tracks Advamedica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Advamedica worth (valuation)?
Valuation information for Advamedica is not publicly available.
Can I buy Advamedica stock?
Advamedica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Advamedica's last funding round?
Advamedica's most recent funding round was Series B Extension on July 27, 2021.
Who are the main investors in Advamedica?
Key investors in Advamedica include GVFL, Omidyar Network India, TrueScale Capital, RNT Associates.
Will Advamedica IPO soon?
No public IPO plans have been announced for Advamedica.
How can I track Advamedica secondary market activity?
Caplight tracks bids, offers, and trades in Advamedica's shares on secondary markets.